HMG-CoA Reductase Degradation 1 (HRD1), as a metabolic enzyme, catalyzes the ubiquitination of PFKP and promotes its degradation, thereby inhibiting the expression and activity of PFKP in cancer cells and obstructing cell invasion and proliferation (95). Here, PFKP is linked to cancer.